Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W. Jacobs, Brian D. Adkins, Ross M. Fasano et al.|American Journal of Hematology|2024Cited by 15
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyondSotiroula Chatzimatthaiou, Petros Kountouris, Fedele Bonifazi et al.|HemaSphere|2025Cited by 6